Turning Point Therapeutics, Inc. Contracts & Agreements

Agreement and Plan of Merger, dated as of June 2, 2022, by and among Turning Point Therapeutics, Inc., Bristol-Myers Squibb Company and Rhumba Merger Sub Inc (Filed With SEC on June 3, 2022)

Executive Employment Agreement, dated March 25, 2022, by and between the Registrant and Brian Sun, M.S., J.D (Filed With SEC on May 10, 2022)

Non-Employee Director Compensation Policy, as amended (Filed With SEC on May 10, 2022)

First Amendment to Lease, dated October 28, 2021, by and between the Registrant and HCP Callan Road, LLC (Filed With SEC on May 10, 2022)

Turning Point Therapeutics, Inc. Severance Benefit Plan, as amended (C-Suite) November 11, 2021 (Filed With SEC on February 28, 2022)

Clinical Trial Collaboration Agreement, dated October 13, 2021, by and between the Registrant and EQRx, Inc (Filed With SEC on February 28, 2022)

Transition Consulting Agreement, dated February 16, 2022, by and between the Registrant and Annette North (Filed With SEC on February 28, 2022)

Turning Point Therapeutics, Inc. Severance Benefit Plan, as amended (C-Suite) May 4, 2021 (Filed With SEC on August 9, 2021)

Executive Employment Agreement, dated June 22, 2021, by and between the Registrant and Paolo Tombesi (Filed With SEC on August 9, 2021)

First Amendment to Lease, dated June 11, 2021, by and between Registrant and Gateway Torrey Hills LLC (Filed With SEC on August 9, 2021)

First Amendment to Lease Agreement dated May 12, 2021 by and between Turning Point Therapeutics, Inc. and ARE-SD Region No. 44, LLC (Filed With SEC on May 13, 2021)

Amendment No. 1 to the License Agreement, dated March 31, 2021, by and between the Registrant and Zai Lab (Shanghai) Co., Ltd (Filed With SEC on May 5, 2021)

Lease dated April 9, 2021 by and between Turning Point Therapeutics Inc and Gateway Torrey Hills LLC (Filed With SEC on April 13, 2021)

April 5, 2021 Turning Point Therapeutics, Inc. Presentation (Filed With SEC on April 5, 2021)

License Agreement, dated January 10, 2021, by and between the Registrant and Zai Lab (Shanghai) Co., Ltd (Filed With SEC on March 1, 2021)

Underwriting Agreement, dated October 26, 2020, by and among Goldman Sachs & Co. LLC and SVB Leerink LLC, as representatives of the several underwriters named therein (Filed With SEC on October 27, 2020)

Non-Employee Director Compensation Policy as amended June 15, 2020 (Filed With SEC on August 10, 2020)

Executive Employment Agreement, dated June 26, 2020, by and between the Registrant and Andrew Partridge (Filed With SEC on August 10, 2020)

Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the Turning Point Therapeutics, Inc. 2019 Equity Incentive (Filed With SEC on August 10, 2020)

License Agreement, dated July 6, 2020, by and between the Registrant and Zai Lab (Shanghai) Co., Ltd (Filed With SEC on August 10, 2020)

Open Market Sale AgreementSM, August 10, 2020, by and between Turning Point Therapeutics, Inc. and Jefferies LLC (Filed With SEC on August 10, 2020)

Underwriting Agreement, dated May 18, 2020, by and among Goldman Sachs & Co. LLC and SVB Leerink LLC, as representatives of the several underwriters named therein (Filed With SEC on May 19, 2020)

Description of Common Stock (Filed With SEC on March 18, 2020)

Non-Employee Director Compensation Policy as amended January 06, 2020 (Filed With SEC on March 18, 2020)

Executive Employment Agreement, dated February 15, 2020, by and between the Registrant and Siegfried Reich, Ph.D (Filed With SEC on March 18, 2020)

Turning Point Therapeutics, Inc. Severance Benefit Plan, as amended (C-Suite) February 15, 2020 (Filed With SEC on March 18, 2020)

Transition Separation and Consulting Agreement, dated January 9, 2020, by and between Jingrong Jean Cui, Ph.D. and Turning Point Therapeutics, Inc (Filed With SEC on January 9, 2020)

Executive Employment Agreement, dated October 30, 2019, by and between the Registrant and Mohammad Hirmand, M.D (Filed With SEC on November 4, 2019)

Form of Underwriting Agreement (Filed With SEC on September 3, 2019)

Executive Employment Agreement, dated July 25, 2019, by and between the Company and Yi Larson (Filed With SEC on July 29, 2019)

Turning Point Therapeutics, Inc. Severance Benefit Plan C-Suite, as amended (Filed With SEC on July 29, 2019)

Lease dated June 19, 2019 by and between Turning Point Therapeutics, Inc., and ARE-SD Region No. 44, LLC (Filed With SEC on June 21, 2019)

Third Amendment to Lease, dated June 19, 2019 by and between Turning Point Therapeutics, Inc., and ARE-SD Region No. 44, LLC (Filed With SEC on June 21, 2019)

Form of Underwriting Agreement (Filed With SEC on April 8, 2019)

Form of Common Stock Certificate of the Registrant (Filed With SEC on April 8, 2019)

Form of Indemnity Agreement by and between the Registrant and its directors and officers (Filed With SEC on April 8, 2019)

Turning Point Therapeutics, Inc. 2019 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise (Filed With SEC on April 8, 2019)

Turning Point Therapeutics, Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on April 8, 2019)

Executive Employment Agreement, dated March 20, 2019, by and between the Registrant and Annette North (Filed With SEC on April 8, 2019)

Non-Employee Director Compensation Policy (Filed With SEC on April 8, 2019)

Fourth Amended and Restated Investor Rights Agreement, dated October 18, 2018, by and among the Registrant and certain of its securityholders (Filed With SEC on March 21, 2019)

Turning Point Therapeutics, Inc. 2013 Equity Incentive Plan, as amended, and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on March 21, 2019)

Turning Point Therapeutics, Inc. Severance Benefit Plan (C-Suite) (Filed With SEC on March 21, 2019)

Turning Point Therapeutics, Inc. Severance Benefit Plan (SVP/VP) (Filed With SEC on March 21, 2019)

Executive Employment Agreement, dated September 29, 2018, by and between the Registrant and Athena Countouriotis, M.D (Filed With SEC on March 21, 2019)

Amended and Restated Executive Employment Agreement, effective as of January 17, 2019, by and between the Registrant and Jingrong Jean Cui, Ph.D (Filed With SEC on March 21, 2019)

Executive Employment Agreement, dated September 29, 2018, by and between the Registrant and Yishan (Peter) Li, Ph.D., M.B.A (Filed With SEC on March 21, 2019)

Consulting Agreement by and between the Registrant and Sheila K. Gujrathi, M.D. dated as of November 14, 2017 (Filed With SEC on March 21, 2019)

Lease, dated January 19, 2016, as amended, by and between the Registrant and Walton Torrey Owner A, L.L.C (Filed With SEC on March 21, 2019)

Category

Industry

Companies

Contracts

Turning Point Therapeutics, Inc. Contracts & Agreements